Kbp Biosciences is Drug Discovery in United States that focus on own medicinal chemistry business. Founded in 2007. They cover business area such as operator, unmet medical need, cardiovascular, respiratory, inflammatory, and autoimmune disease, development, commercialization, innovative medicine, area, its own medicinal chemistry, regulatory expertise, healthcare provider, patient, cardio-renal and infectious disease.
2007
( 17 years old in 2024 )
Own Medicinal Chemistry
-
116 Village Boulevard
Suite 210
Princeton, NJ 08540
United States
Private
operatorunmet medical needcardiovascular, respiratory, inflammatory, and autoimmune diseasedevelopmentcommercializationinnovative medicineareaits own medicinal chemistryregulatory expertisehealthcare providerpatientcardio-renal and infectious disease
* We use standard office opening hours in near Kbp Biosciences's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Kbp Biosciences is Drug Discovery business from United States that founded in 2007 (17 years old in 2024), Kbp Biosciences business is focusing on Own Medicinal Chemistry.
Kbp Biosciences headquarter office and corporate office address is located in 116 Village Boulevard Suite 210 Princeton, NJ 08540 United States.
Kbp Biosciences was founded in United States.
In 2024, Kbp Biosciences is currently focus on own medicinal chemistry sector.
Above is snippet of Google Trends for "own medicinal chemistry" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Kbp Biosciences, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
